Approval · Notice of Compliance 7193 · 2005
ACLASTA: Notice of Compliance 7193
Issued June 30, 2005
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 7193
- Date
- June 30, 2005
- Company
- Novartis Pharmaceuticals Canada Inc.Montreal, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Priority
- Therapeutic class
- Bone metabolism regulator
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ACLASTA | 02269198 | Marketed |
Medicinal ingredients
- ZOLEDRONIC ACID 5 MG per 100ML